State of the art Mass Spectrometry methods for mAbs, ADCs and Bispecifics characterization
Alain Beck joined us at the World Biosimilar Congress 2013 to lead the disucssion in State of the art Mass Spectrometry methods for mAbs, ADCs and Bispecifics characterization.
Download his presentation now to find out more about:
(1) mAbs characterization
-Emerging Mass Spec methods
-Native MS, Ion Mobility-MS, CESI-MS
-Case studies: Trastuzumab, Rituximab, Cetuximab
-Biosimilars, Biobetters
(2) ADCs
-ADC platforms
-IdeS (middle up & down)
-High Resolution-MS
(3) Bispecifics
-HR-MS, Native MS, IM-MS
(4) Summary and take homes messages
-OptimAbs, OptimADCs, OptiBiSpecs
Thank you for downloading the presentation. To receive your copy of the PDF, please fill in the form to your right.
Thanks,
World Biosimilar Congress Team.